Open AccessEffect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer
Author(s) -
L. Elit,
Anthony Fyles,
ChuShu Gu,
Gregory R. Pond,
David D’Souza,
Rajiv Samant,
Margaret Anthes,
Gillian Thomas,
Marc L. Filion,
Julie Arsenault,
Ian S. Dayes,
Timothy J. Whelan,
Karen Y. Gulenchyn,
Ur Metser,
Kavita Dhamanaskar,
Mark N. Levine
Publication year - 2018
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2018.2081
Subject(s) - positron emission tomography , cervical cancer , brain positron emission tomography , medicine , nuclear medicine , preclinical imaging , medical physics , radiology , cancer , biology , microbiology and biotechnology , in vivo
Key Points Question In women with locally advanced carcinoma of the cervix who are candidates for chemotherapy and radiotherapy, does adding fludeoxyglucose F 18 positron emission tomography–computed tomography (PET-CT) to staging with CT of the abdomen and pelvis detect more extensive disease and influence therapy? Findings In a randomized clinical trial, 44 of 112 patients receiving PET-CT compared with 14 of 56 patients receiving CT alone received more extensive chemotherapy and radiotherapy or palliative treatment, a nonsignificant difference. Five percent of patients in each group were treated with palliative intent. Meaning In this trial among women with locally advanced carcinoma of the cervix, there was no significant difference between PET-CT plus CT vs CT alone, possibly because the trial was underpowered.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom